Relay Therapeutics Inc

Market cap: $905,135,335

Exchange: NAS

Sector: Health Technology

Share
Tweet

Relay Therapeutics, Inc. is a clinical-stage precision medicines company. It focuses on using innovative experimental and computational approaches on protein motion for making medicines against intractable precision medicine targets. The company was founded by David Elliot Shaw, Matthew P. Jacobson, Dorothee Kern, Mark Murcko, Alexis Borisy, and Jakob Loven on May 4, 2015 and is headquartered in Cambridge, MA.

Key Statistics

Company Name

Relay Therapeutics Inc

Average Volume (10 days)

1,310,759

Average Volume (30 days)

1,405,328

Moving Average (50 days)

$8.97

Moving Average (200 days)

$9

Ex-Divided Date

n/a

Dividend Yield

0

P/E Ratio

-2.6468

Market Cap

905,135,335

Shares Outstanding

131,179,034

52-Week High Split Adjust Only

19.23

52-Week Low Split Adjust Only

5.95

Employee Count

339

Beta

1.787

Next Earnings Date

2024-05-02

TTM Dividend Rate Per Share

0

Price Changes

Past 5 days

-0.17%

Past 30 days

-0.32%

Past 3 months

-0.4%

Past 6 months

-0.17%

Past year

-0.62%

Past 2 years

-0.77%

Past 5 years

-0.8%

Max % Change

-0.8%

PEER GROUP COMPARATIVE PERFORMANCE

NameTickerPrice/Sales (ttm)Price/Book (ttm)Forward P/EPEG RatioEV/Revenue
Relay Therapeutics IncRLAYn/an/a-17.2n/an/a
Peer AvgN/An/an/a-1.9n/an/a
Omega Therapeutics IncOMGAn/an/an/an/an/a
Oncorus IncONCRn/an/a-7.4n/an/a